BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10378541)

  • 1. Impact of revised stage classification of lung cancer on survival: a military experience.
    Adebonojo SA; Bowser AN; Moritz DM; Corcoran PC
    Chest; 1999 Jun; 115(6):1507-13. PubMed ID: 10378541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002.
    Sawabata N; Asamura H; Goya T; Mori M; Nakanishi Y; Eguchi K; Koshiishi Y; Okumura M; Miyaoka E; Fujii Y;
    J Thorac Oncol; 2010 Sep; 5(9):1369-75. PubMed ID: 20683209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients.
    Rena O; Massera F; Robustellini M; Papalia E; Delfanti R; Lisi E; Pirondini E; Turello D; Casadio C
    Cancer J; 2010; 16(2):176-81. PubMed ID: 20404615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative prognosis in patients with non-small cell lung cancer with synchronous ipsilateral intrapulmonary metastasis.
    Yoshino I; Nakanishi R; Osaki T; Hasuda S; Taga S; Takenoyama M; Yoshimatsu T; Yasumoto K
    Ann Thorac Surg; 1997 Sep; 64(3):809-13. PubMed ID: 9307478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How well does the new lung cancer staging system predict for local/regional recurrence after surgery?: A comparison of the TNM 6 and 7 systems.
    Pepek JM; Chino JP; Marks LB; D'amico TA; Yoo DS; Onaitis MW; Ready NE; Hubbs JL; Boyd J; Kelsey CR
    J Thorac Oncol; 2011 Apr; 6(4):757-61. PubMed ID: 21325975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
    Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
    J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.
    Koshy M; Fedewa SA; Malik R; Ferguson MK; Vigneswaran WT; Feldman L; Howard A; Abdelhady K; Weichselbaum RR; Virgo KS
    J Thorac Oncol; 2013 Jul; 8(7):915-22. PubMed ID: 23608815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience.
    Naruke T; Tsuchiya R; Kondo H; Asamura H
    Ann Thorac Surg; 2001 Jun; 71(6):1759-64. PubMed ID: 11426744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non-Small Cell Lung Cancer in the U.S. National Cancer Data Base.
    Osarogiagbon RU; Lin CC; Smeltzer MP; Jemal A
    J Thorac Oncol; 2016 Jan; 11(1):e5-16. PubMed ID: 26762752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer.
    Gao SJ; Corso CD; Wang EH; Blasberg JD; Detterbeck FC; Boffa DJ; Decker RH; Kim AW
    J Thorac Oncol; 2017 Feb; 12(2):314-322. PubMed ID: 27720827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative radiotherapy increases locoregional control of patients with stage IIIA non-small-cell lung cancer treated with induction chemotherapy followed by surgery.
    Taylor NA; Liao ZX; Stevens C; Walsh G; Roth J; Putnam J; Fossella F; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):616-25. PubMed ID: 12788166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution.
    Kameyama K; Takahashi M; Ohata K; Igai H; Yamashina A; Matsuoka T; Nakagawa T; Okumura N
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1180-4. PubMed ID: 19379988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer prognosis before and after recurrence in a population-based setting.
    Consonni D; Pierobon M; Gail MH; Rubagotti M; Rotunno M; Goldstein A; Goldin L; Lubin J; Wacholder S; Caporaso NE; Bertazzi PA; Tucker MA; Pesatori AC; Landi MT
    J Natl Cancer Inst; 2015 Jun; 107(6):djv059. PubMed ID: 25802059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The results of modern surgical therapy for multiple primary lung cancers.
    Adebonojo SA; Moritz DM; Danby CA
    Chest; 1997 Sep; 112(3):693-701. PubMed ID: 9315801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA.
    van Rens MT; de la Rivière AB; Elbers HR; van Den Bosch JM
    Chest; 2000 Feb; 117(2):374-9. PubMed ID: 10669677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic stratification of patients with T3N1M0 non-small cell lung cancer: which phase should it be?
    Kilicgun A; Tanriverdi O; Turna A; Metin M; Sayar A; Solak O; Urer N; Gurses A
    Med Oncol; 2012 Jun; 29(2):607-13. PubMed ID: 21431959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome after en bloc resection of non-small-cell lung cancer invading the pulmonary sulcus and spine.
    Collaud S; Waddell TK; Yasufuku K; Pierre AF; Darling GE; Cypel M; Rampersaud YR; Lewis SJ; Shepherd FA; Leighl NB; Cho J; Bezjak A; Tsao MS; Keshavjee S; de Perrot M
    J Thorac Oncol; 2013 Dec; 8(12):1538-44. PubMed ID: 24389435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification?
    Wei S; Asamura H; Kawachi R; Sakurai H; Watanabe S
    J Thorac Oncol; 2011 Feb; 6(2):310-8. PubMed ID: 21206387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.